The Max Foundation Welcomes Bryan Murphy-Eustis as Vice President of Programs

The Max Foundation Welcomes Bryan Murphy-Eustis as Vice President of Programs

We are delighted to announce that Bryan Murphy-Eustis, MBA, MPH, is joining The Max Foundation’s Executive Team as Vice President of Programs.

Bryan joins the team with more than 18 years of experience building and leading high-impact mission-driven teams, most recently as Commercialization Lead for Medical Technologies at Global Good at Intellectual Ventures. Previously he served as Executive Director of PIH Liberia and Chief Operating Officer of Ebola Responses at Partners in Health, where he led clinical and operational teams that rapidly initiated and scaled services to 20 treatment facilities across two countries.

“It’s an incredible privilege to be joining The Max Foundation,” says Bryan. “That so many people are still prohibited from accessing live-saving medication is a grave injustice. I’ve long been familiar with The Max Foundation’s amazing work and I am honored to support such a vital effort toward increasing access to care.”

The Max Foundation CEO, Pat Garcia-Gonzalez, notes: “We added the VP of Programs position at our organization to reflect our growing commitment to patients and the long-term sustainability of our programs. As someone deeply committed to mission and impact and with a strong background in operations, Bryan fits right in. I look forward to working closely with Bryan to develop our potential towards a vision where all people can face cancer with dignity and hope.”

We’re excited about Bryan’s invaluable experience to help us shape a new decade of growth and impact for bridging access to treatment and care for people facing cancer worldwide.

Please join us in welcoming Bryan to The Max Foundation team!

See All News

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • The Max Foundation expands collaboration with Pfizer

    The Max Foundation expands collaboration with Pfizer

    The Max Foundation is pleased to announce a significant expansion of its collaboration with Pfizer to provide access to some of Pfizer’s innovative oncology portfolio to patients in low- and middle-income countries, which otherwise would have limited local access. The latest agreement increases the total number of patients benefitting from the program from 270 to 500 patients and adds Inlyta® (axitinib) an oral medicine used to treat advanced kidney cancer.

  • Acting with humanity – donating my birthday – supporting cancer patients in Nepal

    Acting with humanity – donating my birthday – supporting cancer patients in Nepal

    Watch webinar on “Overcoming Barriers to Pediatric Cancer Care in Nepal” Last October I had the privilege of visiting Patan Hospital in Nepal on behalf of The Max Foundation. Right then, I knew I would dedicate my next birthday to supporting people in need of cancer treatment in the country by covering the cost of diagnostics….

  • Partner physician article published in Clinical Surgical Oncology

    Partner physician article published in Clinical Surgical Oncology

    An article by one of our partner physicians, Dr. Freddy Gnangnon in Benin, was recently published in Clinical Surgical Oncology. It’s about the management of locally advanced gastrointestinal stromal tumors and how providing access to treatment free of charge improves survival outcomes. Read More